Saffran DC - Search Results

1

Target antigens for prostate cancer immunotherapy.

Saffran DC, Reiter RE, Jakobovits A, Witte ON. Saffran DC, et al. Cancer Metastasis Rev. 1999;18(4):437-49. doi: 10.1023/a:1006333222424. Cancer Metastasis Rev. 1999. PMID: 10855787 Review.

2

Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.

Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE, Jakobovits A. Saffran DC, et al. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2658-63. doi: 10.1073/pnas.051624698. Epub 2001 Feb 13. Proc Natl Acad Sci U S A. 2001. PMID: 11226295 Free PMC article.

3

Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.

Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC, Raitano AB, Jakobovits A. Afar DE, et al. Among authors: saffran dc. Cancer Res. 2001 Feb 15;61(4):1686-92. Cancer Res. 2001. PMID: 11245484

4

STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors.

Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, Madraswala R, Zhou Y, Kuo J, Raitano AB, Jakobovits A, Saffran DC, Afar DE. Hubert RS, et al. Among authors: saffran dc. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14523-8. doi: 10.1073/pnas.96.25.14523. Proc Natl Acad Sci U S A. 1999. PMID: 10588738 Free PMC article.

5

Establishment of a reproducible culture technique for the selective growth of B-cell progenitors.

Saffran DC, Faust EA, Witte ON. Saffran DC, et al. Curr Top Microbiol Immunol. 1992;182:37-43. doi: 10.1007/978-3-642-77633-5_5. Curr Top Microbiol Immunol. 1992. PMID: 1490376 No abstract available.

6

Development of btk transgenic mice.

Faust EA, Rawlings DJ, Saffran DC, Witte ON. Faust EA, et al. Among authors: saffran dc. Curr Top Microbiol Immunol. 1995;194:363-70. doi: 10.1007/978-3-642-79275-5_42. Curr Top Microbiol Immunol. 1995. PMID: 7895510 No abstract available.

7

Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells.

Faust EA, Saffran DC, Toksoz D, Williams DA, Witte ON. Faust EA, et al. Among authors: saffran dc. J Exp Med. 1993 Apr 1;177(4):915-23. doi: 10.1084/jem.177.4.915. J Exp Med. 1993. PMID: 7681470 Free PMC article.

8

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.

Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON. Goga A, et al. Among authors: saffran dc. Cell. 1995 Sep 22;82(6):981-8. doi: 10.1016/0092-8674(95)90277-5. Cell. 1995. PMID: 7553858 Free article.

9

Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.

Saffran DC, Parolini O, Fitch-Hilgenberg ME, Rawlings DJ, Afar DE, Witte ON, Conley ME. Saffran DC, et al. N Engl J Med. 1994 May 26;330(21):1488-91. doi: 10.1056/NEJM199405263302104. N Engl J Med. 1994. PMID: 8164701 Free article. No abstract available.

10

Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).

Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD. Zhu Q, et al. Among authors: saffran dc. J Exp Med. 1994 Aug 1;180(2):461-70. doi: 10.1084/jem.180.2.461. J Exp Med. 1994. PMID: 7519238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page